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Apaf1 Is Required for Mitochondrial Pathways
of Apoptosis and Brain Development
in these situations prevents autoimmune disease and
the inappropriate accumulation of lymphocytes.
Core components of the cell death machinery are con-
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Josef M. Penninger,*² and Tak W. Mak*²³ served from nematodes to humans (Yuan et al., 1993;
Hengartner and Horvitz, 1994; Zou et al., 1997). Genetic*The Amgen Institute
620 University Avenue analyses of Caenorhabditis elegans mutants have iden-
tified two killer genes, ced-3 and ced-4, and an antiapo-Toronto, Ontario
²Ontario Cancer Institute and the Departments ptotic gene, ced-9, that are important for the regulation
of cell death (Horvitz et al., 1983; Ellis and Horvitz, 1986).of Medical Biophysics and Immunology
University of Toronto The ced-9 gene is homologous to the mammalian Bcl2
gene family, some members of which (such as Bcl2 andToronto, Ontario
Canada M5G 2C1 BclX) inhibit PCD, while others (such as Bax and Bak)
promote PCD. The CED-3 protein is homologous to the
proapoptotic cysteine proteases known as the cas-
pases, among which Caspase 3 (Casp3) exhibits theSummary
highest degree of similarity to CED-3 (Yuan et al., 1993;
Fernandes-Alnemri et al., 1994). The caspases can beApoptosis is essential for the precise regulation of
activated by a wide variety of apoptotic stimuli and me-cellular homeostasis and development. The role in vivo
diate PCD by cleaving selected intracellular proteins,of Apaf1, a mammalian homolog of C. elegans CED-4,
including proteins of the nucleus, nuclear lamina, cy-was investigated in gene-targeted Apaf12/2 mice.
toskeleton, endoplasmic reticulum, and cytosol, therebyApaf1-deficient mice exhibited reduced apoptosis in
disabling important cellular processes and breakingthe brain and striking craniofacial abnormalities with
down structural components of the cell (Nicholson andhyperproliferation of neuronal cells. Apaf1-deficient
Thornberry, 1997; Thornberry, 1998).cells were resistant to a variety of apoptotic stimuli,
ced-4 has been determined genetically to functionand the processing of Caspases 2, 3, and 8 was im-
downstream of ced-9 but upstream of ced-3 (Shahampaired. However, both Apaf12/2 thymocytes and acti-
and Horvitz, 1996). APAF1, a mammalian homolog ofvated T lymphocytes were sensitive to Fas-induced
CED-4, (Zou et al., 1997), hasbeen shown to bind CASP9killing, showing that Fas-mediated apoptosis in these
via the caspase recruitment domain (CARD) (Hofmanncells is independent of Apaf1. These data indicate that
et al., 1997) at its NH2 terminus (Li et al., 1997a; Hu etApaf1 plays a central role in the common events of
al., 1998; Pan et al., 1998). In vitro, in the presence ofmitochondria-dependent apoptosis in most death path-
cytochrome c and dATP, this interaction leads to theways and that this role is critical for normal devel-
activation of CASP9 and the subsequent proteolytic ac-opment.
tivation of CASP3 (Li et al., 1997a). Like CED-4, which
has been shown to participate in a ternary complex withIntroduction
CED-9 and CED-3 (Chinnaiyan et al., 1997; Spector et
al., 1997; Wu et al., 1997a, 1997b), APAF1 forms a com-Apoptosis or programmed cell death (PCD) is critical for
plex with BclXL and CASP9 (Hu et al., 1998; Pan et al.,the normal development of the body and occurs in many
1998). Although the roles in PCDof Bcl2 family members,developing tissues in both invertebrates and vertebrates
cytochrome c, and the caspases have been extensively(Clarke and Clarke, 1996; Jacobson et al., 1997). Ratio-
studied, little is known about the function of the keynalization of cell numbers by PCD is particularly impor-
intermediary molecule Apaf1.tant in the developing central nervous system (CNS).
To investigate the biological function of Apaf1 in vivo,Many developing vertebrate neurons are thought to
we generated Apaf12/2 null-mutant mice. Analyses ofcompete for limiting amounts of survival signals (neuro-
Apaf12/2 mice in vivo as well as ex vivo suggest thattrophic factors) secreted by the target cells they inner-
Apaf1 is essential for the normal development of thevate (Oppenheim, 1991; Oppenheim et al., 1991). Only
CNS during embryogenesis. Our results also show thatthat small proportion of neurons receiving sufficient
Apaf1 is a central element in the mitochondrial pathwaysquantities of these signals survives, while the remaining
of PCD induced in response to a wide range of apoptoticcells undergo PCD (Barde, 1989; Oppenheim, 1991).
stimuli, but that Fas-mediated PCD in thymocytes andApoptosis is also essential for the development and
activated T cells is independent of Apaf1.maintenance of the immune system (Nagata, 1997). De-
veloping T lymphocytes that either fail to produce func-
tional antigen-specific receptors or produce self-reac- Results
tive receptors are eliminated by PCD in the thymus. In
the periphery, self-reactive T cells as well as antigen- Generation of Apaf12/2 Mutant Mice
stimulated mature T cells are deleted by a mechanism The Apaf1 gene was disrupted in murine embryonic
of activation-induced cell death mediated by Fas. PCD stem (ES) cells using a targeting vector in which an exon
encoding a portion of the nucleotide-binding P loop was
deleted (see Experimental Procedures and Figure 1A).³To whom correspondence should be addressed.
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Figure 1. Targeted Disruption of the Apaf1
Locus
(A) A portion of the mouse Apaf1 wild-type
locus (top) showing exons (hatched boxes)
and a 9.0 kb HindIII fragment in the wild-type
allele. The targeting vector (middle) was de-
signed to replace an exon encoding a portion
of the nucleotide-binding domains with a
neomycin resistance gene (closed box). The
mutated Apaf1 locus (bottom) contains a 4.0
kb HindIII fragment. The position of the 39
flanking probe used for Southern blot analy-
sis is shown. Positions of PCR primers for the
wild-type allele (a and b) and the mutantallele
(c and d) are also shown. Xb, B, H, and Xh
represent XbaI, BamHI, HindIII, and XhoI
sites, respectively.
(B) Southern blot analysis of wild-type and
mutant ES cell DNA. Genomic DNA from wild-
type ES cells (lanes 1 and 4), three indepen-
dent Apaf11/2 ES cell clones (lanes 2, 3, and
5), and two Apaf12/2 ES cell clones (lanes 6
and 7) were digested with HindIII and hybrid-
ized to the 39 flanking probe. The 9 kb wild-
type fragment and the 4 kb mutant fragment
are indicated.
(C) Northern blot analysis of Apaf1 expres-
sion. Total RNA extracted from E9.5 embryos
(20 mg/lane) was analyzed for the expression
of Apaf1 gene.
The targeting vector was electroporated into ES cells. Apaf1 Gene Expression in the Embryo
and Adult TissuesThree G418-resistant colonies were found to be hetero-
The spatialdistribution of Apaf1 gene expression inwild-zygous for the mutation at the Apaf1 locus (Figure 1B).
type embryos was analyzed by in situ hybridization. AtThe heterozygous mutant ES cells were used to gener-
E9.5, Apaf1 mRNA was strongly expressed in the devel-ate chimeric mice. Chimeras were backcrossed to
oping hindbrain and in the regions lining the third ventri-strains C57BL/6 or CD1 to generate mice heterozygous
cle at the basal telencephalon and diencephalon, andfor the Apaf1 mutation. Heterozygous Apaf11/2 mice
it was weakly expressed along the entire length of thewere healthy and fertile and were intercrossed to gener-
mesencephalon and telencephalon (Figures 2A and 2B).ate homozygous Apaf12/2 mice. The null mutation of
At E12.5 to 14.5, a low level of Apaf1 expression wasApaf1 was confirmed by the absence of Apaf1 expres-
observed ubiquitously throughout the wild-type embryosion as determined by Northern blot analysis of RNA
(data not shown). The expression of Apaf1 was alsoextracted from embryos on day 9.5 of gestation (E9.5)
confirmed in wild-type ES cells, thymocytes, and sple-(Figure 1C). Apaf12/2 ES cells were also established to
nocytes by RT-PCR analysis (data not shown).generate the Apaf12/2/Rag12/2 chimeric mice (Figure 1B).
Histological Analyses of Structural Abnormalities
Perinatal Lethality of Apaf12/2 Mutant Mice in Apaf12/2 Mutant Embryos
Of 190 offspring derived from heterozygous matings, 11 The structural abnormalities of Apaf12/2 mutants were
homozygous Apaf12/2 mutants were identified (Table characterized by histological analyses of serially sec-
1). However, all but three Apaf12/2 mice were found tioned E12.5-E16.5 embryos. Examination of sections
dead at birth or died within 12 hr after birth. To deter- from mutant mice with ectopic masses on the forehead
mine the stage of embryonic development affected by (Figure 3A; phenotype a) revealed that the protrusions
the Apaf1 mutation, timed breedings followed by em- were an extension of the forebrain (Figure 3C). These
bryo genotyping were performed. From E11.5 to E16.5, extensions showed remarkable thickening of the mitotic
Apaf12/2 embryos were viable, usually of normal size, ventricular zone, although the normal layered organiza-
and occurred at the expected Mendelian frequency. tion of the forebrain was maintained (Figure 3C, inset).
However, at E12.5 and thereafter, most Apaf12/2 em- In newborn Apaf12/2 mice, the forebrain masses were
bryos showed morphological abnormalities: (a) ectopic hemorrhagic and necrotic (data not shown). Neverthe-
masses on the forehead; (b) a cauliflower-like mass on less, these types of forebrain masses constituted the
the face; and (c) a cone-shaped head mass with exen- least severe mutant phenotype, because the overall cy-
cephalus. These three phenotypes were observed at toarchitectural structure of the brain was relatively in-
similar frequencies, and the genetic background of mice tact, and the three Apaf12/2 mice that survived until 10
days after birth were of this phenotype.(C57BL/6 or CD1) did not affect the ratio.
Reduced Apoptosis in Apaf1-Deficient Mice
741
Table 1. Genotype Analysis of the Progeny from Apaf1 Heterozygous Intercrosses
No. of the Genotypes (Percentage)
²Phenotype
Stage 1/1 1/2 2/2 (a, b, c, n) Total
E11.5 4 (20) 10 (50) 6 (30) (0, 0, 0, 6) 20
E12.5 8 (29) 14 (50) 6 (21) (1, 1, 1, 3) 28
E13.5 14 (26) 23 (43) 16 (30) (4, 5, 5, 2) 53
E14.5 15 (27) 28 (51) 12 (22) (3, 4, 4, 1) 55
E15.5 11 (25) 20 (45) 13 (30) (4, 4, 5, 0) 44
E16.5 16 (38) 14 (33) 12 (29) (7, 3, 2, 0) 42
E18.5 10 (27) 20 (56) 6 (17) (3, 2, 1, 0) 36
Newborn 63 (33) 116 (61) *11 (6) (7, 2, 2, 0) 190
Total 468
Timed breedings were performed with Apaf1 heterozygous intercrosses. The day when females were plugged was defined as E0.5.
² Phenotype a, forehead masses; b, a face mass; c, a cone-shaped mass; and n, no obvious anomaly (See text).
* Three mutants with masses on the forehead survived up to day 10 after birth.
In mutant embryos with a cauliflower-like mass on the TUNEL assays were used to examine apoptosis in
the brains of mutant and wild-type embryos. Numerousface and a small, flat head (Figures 3D; phenotype b),
striking deformities of the thalamus, hypothalamus, and TUNEL-positive cells indicating the presence of apo-
ptotic nuclei were observed in the hindbrain of E14.5forebrain were observed (compare Figures 3F and 3G
with the wild type in 3E). The thalamic areas of the wild-type embryos (Figure 3J), whereas fewer TUNEL-
positive cells were detected in the corresponding areamutant embryos were filled with supernumerary cells,
producing a wedge-shapeddeformation (Figure 3F). The of the mutant embryo (Figure 3K; phenotype c). The
mutant embryos also exhibited reduced apoptosis incauliflower-like mass on the face stained positively for
neurofilament light chain (data not shown), thus identi- the roof of the midbrain and the cortex of the forebrain
(both in embryos with phenotype b and c) at E14.5 (datafying it histologically to be forebrain tissue. This mass
exhibited significant thickening of the cortex but a nor- not shown). Other areas, such as mesenchymal tissue
in the brain, showed no difference in PCD (data notmal layering pattern (data not shown). Significant hyper-
plasia of the choroid plexus of these animals was also shown). These results demonstrate that apoptosis was
dramatically reduced in the developing brain of Apaf12/2observed.
In Apaf12/2 embryos with a cone-shaped head mass embryos.
The supernumerary cells in the thalamic areas of phe-and exencephalus (Figure 3H; phenotype c), ectopic
masses were observed (Figure 3I; asterisk), probably notype b or in the ectopic mass of phenotype c (Figures
3G and 3I, asterisks) showed increased mitotic activityresulting from an overgrowth of the thalamus and hypo-
thalamus. Mutants of this phenotype also displayed a at E14.5 compared to thecontrol as determined by BrdU
incorporation (data not shown). However, by E16.5,remarkably extended hindbrain (Figure 3I, inset).
The primary cause of death of most Apaf12/2 embryos BrdU incorporation had ceased in these areas (data not
shown), suggesting that the supernumerary cells wereappeared to be mechanical disruption of the brain
masses during delivery, since most mutants appeared not proliferating tumors. The increased BrdU incorpora-
tion in the mutant embryos was detected in other areas,viable and were found at the expected Mendelian fre-
quency when dissected (Table 1). However, because such as in the hindbrain at E12.5 and in the forebrain at
E13.5 (Figures 3L±3O). Mutant embryos exhibited higherthe frequency of Apaf12/2 embryos at E18.5 was already
lower than that predicted by Mendelian genetics, some labeling index (labeled nuclei per total nuclei) than wild-
type littermates: 15.7% 6 2.9% vs. 10.1% 6 1.1% inmutants, especially those with phenotypes b and c, ap-
peared to die before birth (Table 1), possibly suc- the hindbrain at E12.5 and 40.2% 6 5.8% vs. 19.9% 6
4.8% in the forebrain at E13.5; mutant versus wild type.cumbing to secondary effects such as hydrocephalus.
Figure 2. Expression of Apaf1 in the Brain of
a Wild-Type Embryo
(A) Whole-mount in situ hybridization of an
E9.5 wild-type embryo. Apaf1 expression
(purple) was strongly detected in the region
of the developing hindbrain (arrowhead). The
expression was also detected in the basal
telencephalon and diencephalon (arrows).
Weak expression was detected ubiquitously
along the mesencephalon and the remainder
of telencephalon. Original magnification, 403.
(B) Higher power view of the same embryo.
Original magnification, 643.
(C) Negative control: no signal was detected
with a probe in a sense orientation.
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Figure 3. Phenotypes of Apaf12/2 Embryos
(A) Protrusion of brain tissue on the frontal bone area (arrowhead) at E15.5.
(B and C) Cytoarchitectural organization of wild-type (B) and mutant (C) mice at E16.5; parasagittal section. An arrowhead shows the protrusion
of forebrain with thickening of the cortex. Insets show high-power views of the forebrains; the normal layered pattern observed in wild-type
mice is maintained in mutant mice. Bar, 500 mm.
(D) Craniofacial abnormality with a cauliflower-like mass on the face (arrowhead) and small head (chevron) of an Apaf12/2 embryo at E14.5.
(E and F) Horizontal views of wild-type (E) and Apaf12/2 (F) embryos at E14.5 showing the wedge-shaped deformity of thalamus and
hypothalamus with supernumerary cells in the mutant. Remarkable thickening of forebrain (arrowhead) and hyperproliferation of the choroid
plexus (cp) in the mutant can also be seen. t, thalamus; h, hypothalamus; and p, pons. Insets show the third ventricles; the third ventricle in
the mutant shows complete occlusion.
(G) A sagittal view of an Apaf12/2 embryo at E14.5. The abnormally shaped thalamic area with the head deformity is prominent (asterisk). mb,
midbrain; fb, forebrain.
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A Delay in Removal of Interdigital Webs EF cells, cytochrome c displayed punctate staining pat-
tern consistent with its localization in mitochondria. Fol-in Apaf12/2 Mutant Embryos
The formation of digits in higher vertebrate species is a lowing stimulation with etoposide, staurosporine, or UV
irradiation, both Apaf11/2 and Apaf12/2 EF cells exhib-well-studied example in which PCD eliminates the cells
between developing digits (Jacobson et al., 1996). ited mostly diffuse cytoplasmic cytochrome c staining,
consistent with its translocation from mitochondria toApaf12/2 embryos showed poorly shaped digits with a
delay in the removal of interdigital webs of forelimbs at cytoplasm (Bossy-Wetzel et al., 1998). Thus the release
of cytochrome c is not impaired in Apaf12/2 EF cells inE13.5 (4 out of 16) and of hindlimbs at E14.5 (4 out of
12) (Figure 3Q and data not shown). However, at E15.5 response to these stimuli, suggesting that Apaf1 acts
downstream of cytochrome c release.and later, apparently normal development of digits and
removal of interdigital webs were seen in all mutant
embryos. Apaf12/2 Thymocytes Are Resistant to Various
Apoptotic Stimuli but Sensitive
to Fas-Mediated KillingResistance of Apaf12/2 ES Cells and Embryonic
Fibroblasts to Various Apoptotic Stimuli Since PCD plays a critical role in thymocyte selection,
we investigated whether the Apaf1-mediated apoptoticTo investigate the role of Apaf1 in PCD of various cell
types, we examined the susceptibility of Apaf12/2 ES pathway was involved in the development of thymocytes.
Thymic development was examined in three Apaf12/2and embryonic fibroblast (EF) cells to apoptotic stimuli.
Apoptosis of Apaf11/2 and Apaf12/2 ES cells was in- mice that had survived until 10 days of age. Thymi from
Apaf12/2 mice yielded fewer thymocytes (90 6 12 3 106)duced by treatment with either anisomycin, cisplatinum,
etoposide, or UV irradiation. Six or 24 hr after induction than heterozygous (230 6 30 3 106) littermates, but this
number was proportional to the smaller body size of theof PCD, cells were evaluated for apoptotic cell death by
propidium iodide (PI) staining and annexin V costaining. mutants. Flow cytometric analyses of Apaf12/2 thymo-
cytes revealed normal development of CD41 and CD81Annexin V staining detects the loss of cell membrane
phospholipid asymmetry; in particular, phosphatidylser- cells (data not shown). Normal thymocyte development
in the absence of Apaf1 was also confirmed in Apaf12/2/ine becomes exposed to the outer membrane during
the early phases of apoptosis (Fadok et al., 1992). Al- Rag12/2 chimeric mice (data not shown). Therefore, the
apoptotic pathway required for normal thymocyte devel-though a low level of cell death occurred afterUV irradia-
tion, Apaf12/2 ES cells were generally protected from opment does not require Apaf1.
We then examined the susceptibility of Apaf12/2 thy-PCD induced by all stimuli tested (Figure 4A). Moreover,
there was virtually no increase in the annexin V-positive mocytes to various apoptotic stimuli. In contrast to
Casp32/2 thymocytes, but similar to Casp92/2 thymo-population in Apaf12/2 ES cells following stimulation.
We also examined the susceptibility of primary EF cytes (Kuida et al., 1996, 1998; Hakem et al., 1998; Woo
et al., 1998), Apaf12/2 thymocytes were resistant to acells to apoptotic stimuli (Figure 4B). Compared to het-
erozygous EF cells, Apaf12/2 EF cells were also pro- wide range of apoptotic stimuli, particularly dexametha-
sone (Dex), etoposide, and g-irradiation (Figures 5A andtected from PCD induced by all stimuli tested, although
they were not as resistant as Apaf12/2 ES cells. A sub- 5B). However, Apaf12/2 thymocytes showed normalsus-
ceptibility to Fas-mediated cell death, demonstratingstantial increase in the proportion of Apaf12/2 EF cells
staining positively for annexin V was observed. The dif- that Apaf1 is dispensable for the Fas-mediated apo-
ptotic pathway in thymocytes.ference in degree of resistance to apoptotic stimuli be-
tween Apaf12/2 ES and EF cells suggests a differential
requirement for Apaf1 in the apoptotic machinery of Activated Apaf12/2 Peripheral T Cells Are Resistant
to UV Irradiation but Sensitivedifferent cell types.
to Fas-Mediated Killing
To determine the involvement of Apaf1 in the PCD ofCytochrome c Release Is Not Impaired
in Apaf12/2 EF Cells activated peripheral T cells, the response of these cells
to treatment with UV irradiation or Fas ligation was ex-Cytochrome c is required for the APAF1-mediated pro-
teolytic activation of CASP9 (Li et al., 1997a). We exam- amined. Equal numbers of heterozygous and homozy-
gous cells were killed by Fas ligation (percentages ofined the effect of Apaf1 on cytochrome c release from
mitochondria by immunofluoresence microscopy in EF viable cells remaining were 71.4% 6 3.0% and 65.0% 6
4.0% at 6 hr, and 46.0% 6 4.9% and 38.1% 6 4.2% atcells (Figure 4C). In both Apaf11/2 and Apaf12/2 untreated
(H) An Apaf12/2 mutant (E13.5) showing a cone-shaped mass on the head (arrowhead) and exencephalus (white arrowhead).
(I) A sagittal view of an Apaf12/2 embryo (E14.5) showing an ectopic mass (asterisk) and extended hindbrain. Inset, a high-power view of the
area in the square showing a ventricular zone exposed outside due to the extended hindbrain.
(J and K) TUNEL assay showing the reduced apoptosis in the Apaf12/2 mutant ([K]; phenotype c) compared with that in the wild type ([J],
arrowheads). Areas of the hindbrain in sagittally cut sections (E14.5) were stained for apoptotic nuclei.
(L±O) BrdU incorporation in brains of wild-type and Apaf12/2 embryos. Areas in the forebrain of wild-type (L) and mutant ([M]; phenotype b)
at E13.5 and areas in the hindbrain of wild-type (N) and mutant ([O]; phenotype b) at E12.5 are shown.
Original magnifications: (B), (C), (E)±(G), and (I), 253; (J) and (K), 4003; (L)±(O), 2003.
The frontal mass in (D) and the rostral mass in (H) are assumed to be lost during delivery.
(P and Q) Delayed removal of interdigital webs in Apaf12/2 embryos. Hind limb of wild-type (P) and Apaf12/2 mutant (Q) embryos at E14.5
showing a delay in the removal of the interdigital webs in the mutant.
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Figure 4. Resistance of Apaf12/2 ES and EF Cells to Various Apoptotic Stimuli
(A) Resistance of Apaf12/2 ES cells. Apaf11/2 and Apaf12/2 ES cells were stimulated for the induction of apoptosis and evaluated for cell
death as described in Experimental Procedures. Data from inductions with anisomycin, etoposide (100 mM), cisplatinum (50 mM), and UV
irradiation are shown.
(B) Resistance of Apaf12/2 EF cells. EF cells were stimulated as in (A). Data from stimulations with etoposide (100 mM), staurosporine (2 mM),
cisplatinum (50 mM), and UV irradiation are shown.
(Left) annexin V vs. PI staining after 24 hr treatment with apoptotic stimuli. Number in each panel represents the percentage of cells in that
quadrant.
(Right) Cell viability after induction of apoptosis. The percentages of viable cells (annexin V±negative and PI-negative cell population) after
stimulation are shown. The figures show data representative of three independent experiments.
(C) Cytochrome c release visualized by immunofluorescence microscopy.
Intracellular localization of cytochrome c (green) and nuclear morphology (red) is shown in untreated, etoposide-, staurosporine-, and UV-
treated EF cells. Top, Apaf11/2; bottom, Apaf12/2 EF cells. Bar, 20 mm.
12 hr, heterozygous and homozygous mutant, respec- DCm in response to Fas-mediated killing was similar in
Apaf12/2 and control thymocytes (Figure 5C), confirmingtively). However, significantly more heterozygous cells
underwent PCD in response to UV irradiation than did that the Fas-mediated apoptotic pathway is indepen-
dent of Apaf1. However, DCm was maintained in thehomozygous mutant cells (8.8% 6 1.0% vs. 27.4% 6
5.0% viable cells at 6 hr). Thus, activated Apaf12/2 pe- Apaf12/2 thymocytes compared with control thymo-
cytes in response to other apoptotic stimuli. This resultripheral T cells are resistant to UV irradiation to some
degree, but Apaf1 is dispensable for Fas-mediated cell suggests that Apaf12/2 thymocytes are protected not
only from apoptotic death but also from mitochondrialdeath in activated peripheral T cells.
changes and indicates that Apaf1 lies upstream of these
apoptotic changes as exemplified by the loss of DCm.Resistance to the Loss of Mitochondrial
Transmembrane Potential (DCm)
in Apaf12/2 Thymocytes Activation of Casp2, Casp3, and Casp8
in Apaf12/2 ThymocytesTo explore further the mechanism of resistance to apo-
ptosis in Apaf12/2 cells, the potential-sensitive dye 3, To determine the consequences of the Apaf1 mutation
on the caspase cascade, we examined the activation of39-dihexyloxacarbocyanine iodide (DiOC6(3)) (Petit et al.,
1995) was used to evaluate changes in the mitochondrial Casp3 in Apaf12/2 thymocytes (Figure 6A). As expected,
theactivation of Casp3 as demonstrated by the cleavagetransmembrane potential (DCm) following the induction
of apoptosis in thymocytes. As expected, the loss of of its procaspase form was equivalent in mutant and
Reduced Apoptosis in Apaf1-Deficient Mice
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Figure 5. Resistance of Apaf12/2 Thymo-
cytes to Various Apoptotic Stimuli
(A and B) Thymocytes from Apaf12/2 or
Apaf11/2 mice were stimulatedwith apoptotic
stimuli, anti-Fas antibody (1.0 mg/ml) plus
cycloheximide (CyH;0±1.0 mg/ml), dexameth-
asone (1±1000 nM), etoposide (2±50 mM),
staurosporine (0.5±10 mM), and g-irradiation
(100±1000 rad), as described in Experimental
Procedures. Apoptotic cell death was evalu-
ated by annexin V vs. PI staining 20 hr after
stimulation. Experiments wererepeated three
times in triplicate using newborn Apaf12/2 or
Apaf12/2/Rag12/2 chimeric mice with similar
results. (A) shows the mean 6 SD.
(C) Resistance to the loss of mitochondrial
transmembrane potential in Apaf12/2 thymo-
cytes. Thymocytes from Apaf12/2 and control
mice were left untreated or treated with apo-
ptotic stimuli as above. The loss of mitochon-
drial transmembrane potential (DCm) was
evaluated by DiOC6(3) staining 6 hr after stim-
ulation. The number in each panel shows the
percentage of the cell population exhibiting
a low transmembrane potential.
(B) and (C) show the data from stimulations
with anti-Fas antibody plus CyH (1 mg/ml),
Dex (1000 nM), etoposide (50 nM), stauro-
sporine (10 nM), and g-irradiation (1000 rad).
control thymocytes in response to Fas ligation (right processing of Casp3 and Casp8, Casp2 cleavage was
panel, ªFasº lanes), consistent with the finding that unimpaired during Fas-mediated cell death in Apaf12/2
Casp3 can be activated independently of mitochondrial thymocytes. Although not the only possible explanation,
activation in Fas-induced apoptosis (Scaffidi et al., these results would be consistent with a scheme in
1998). In contrast, when Dex or etoposide was used to which Casp8 and Casp2 are regulatory targets down-
induce PCD, the activation of Casp3 was greatly re- stream of Apaf1. In any case, it is clear that the Fas-
duced compared to controls (ªDexº and ªEtopº lanes), mediated apoptotic pathway is able to activate these
correlating with the observed maintenance of DCm and caspases independently of Apaf1.
cell death (Figure 5) and demonstrating that Casp3 is
indeed regulated downstream of Apaf1.
DiscussionTo determine whether the absence of Apaf1 affects
the activation of other caspases, we examined the pro-
The Role of Apaf1 in the Developmentteolytic processing of proCasp8 and proCasp2. The pro-
of the Embryoteolytic activation of Casp8 was greatly reduced in
In this study, we have generated a null mutation of theApaf12/2 thymocytes stimulated with Dex or etoposide
Apaf1 gene in mouse ES cells. The Apaf1 mutation had(Figure 6B), suggesting that Apaf1 can indeed affect
a striking effect on the development of the brain duringthe activation of Casp8 in response to these stimuli.
embryogenesis that resulted in perinatal lethality. Mu-In contrast, proCasp8 processing was not impaired in
tant embryos showed increase in the number of prolifer-Apaf12/2 thymocytes after anti-Fas antibody treatment,
ating cells concomitant with markedly reduced apopto-indicating that Casp8 activation in response to Fas stim-
sis in the affected areas. The mutation also appearedulation can be independent of Apaf1. The activation of
to affect the development of digits.Casp2 was also reduced in Apaf12/2 thymocytes stimu-
Apoptosis determines the cytoarchitecture of the ma-lated with Dex (Figure 6C). Moreover, p12, the active
ture CNS to a significant degree (Blaschke et al., 1996;subunit derived from p14 (Li et al., 1997b), was not de-
tected in Dex-treated Apaf12/2 thymocytes. Like the Weller et al., 1997). Recent studies on the rate of cortical
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mal survival and accumulation of the cells, as demon-
strated by the increased BrdU-positive cells and a vast
excess of neural cells in the mutant (Figure 3). Thus,
Apaf1, Casp9, and Casp3 act in line in a common apo-
ptotic pathway of developing CNS, as has been demon-
strated in vitro (Li et al., 1997a; Zou et al., 1997). How-
ever, Apaf12/2 mice were more drastically affected than
Casp32/2 or Casp92/2 mice in terms of the extent of the
affected areas in the brain and the severity of the brain
deformity. For example, mutant mice with ectopic masses
on the forehead, most often observed in Casp32/2 and
Casp92/2 embryos, appeared to be the least severe mu-
tant phenotype among Apaf1 mutant embryos. More-
over, the phenotype of a cauliflower-like mass on the
face (Figure 3D) was not observed in either Casp32/2 or
Casp92/2 embryos. These differences raise the possibil-
ity that additional caspase(s) may also be regulated by
Apaf1 during apoptosis in the brain. The observation
that the delay in the removal of interdigital webs (Figure
Figure 6. Caspase Activation in Apaf12/2 Thymocytes 3Q) has not been observed in either Casp3 or Casp9
Western blot analysis of the proteolytic activation of caspases in mutant embryos also supports this possibility. Interest-
Apaf12/2 thymocytes. Thymocytes were either left untreated in me-
ingly, although Apaf1 is expressed ubiquitously in em-dium (Med) or were stimulated with anti-Fas antibody (Fas; 1.0 mg/
bryos at the later stages of development (Zou et al.,ml), dexamethasone (Dex; 1 mM, left panels or 5 nM, right panels),
1997, and data not shown), the mutant phenotypes areor etoposide (Etop; 10 mM). Protein lysates were prepared 6 hr
after stimulation and Western-blotted as described in Experimental most obvious in those areas of the brain (hindbrain and
Procedures. thalamic areas) where Apaf1 is strongly expressed
(A) Activation of Casp3. Proteolytic cleavage of the p32 form of (E9.5). This restricted phenotype implies that other
Casp3 was absent after dexamethasone or etoposide treatment of
Apaf1-like molecule(s) exist that play equivalent roles inApaf12/2 thymocytes (left panel) but present after anti-Fas antibody
the development of other organs and tissues as welltreatment (right panel).
as in other areas of the brain. This hypothesis is also(B) Activation of Casp8. Cleavage of Casp8 was reduced in Apaf12/2
thymocytes treated with either dexamethasone or etoposide. supported by the considerable variation in the severity
(C) Activation of Casp2. Cleavage of Casp2 to the p14 and p12 of the phenotypes of Apaf12/2 mice and by the fact that
forms was reduced in Apaf12/2 thymocytes treated with dexametha- an initial deficit in digit development in the mutants was
sone but detected when Apaf12/2 cells were induced with anti-Fas
overcome at later stages of development.antibody.
The b-actin blots are shown as internal controls. Arrowheads indi-
cate the procaspases forms, and arrows indicate the processed
The Role of Apaf1 in the Immune Systemforms of each caspase.
Apoptosis is also critical for immune system develop-
ment and homeostasis. In the thymus, the processes of
positive and negative thymocyte selection exerted byneurogenesis have indicated that cell production in-
creases exponentially during brain development (Cavi- the surrounding stroma result in the PCD of over 97%
of developing thymocytes (Shortman et al., 1990; Surhness et al., 1995; Takahashi et al., 1995). However, the
newly produced neurons undergo PCD unless they are and Sprent, 1994). In the periphery, Fas-mediated PCD
eliminates self-reactive lymphocytes and controls thestimulated by nerve growth factor (NGF) released by
their target cells (Blaschke et al., 1996). This depen- expansion of antigen-stimulated T cells (Nagata, 1997).
However, despite the involvement of PCD in thymic se-dence on limiting amounts of target cell±derived survival
signals is believed to be a mechanism for matching the lection, there were no obvious abnormalities in thy-
mocyte development in either newborn Apaf12/2 ornumber of neurons to the number of target cells that
need to be innervated, thus eliminating those neurons Apaf12/2/Rag12/2 chimeric mice. Apaf1 thus appears to
be dispensable for the apoptotic pathway regulatingconnecting to inappropriate target cells (Jacobson et
al., 1997). thymocyte development, although an impairment of
negative selection has not yet been ruled out.Consistent with this view, mice with a targeted dis-
ruption of Casp3, Casp9, or Apaf1 die perinatally with Apaf1-deficient thymocytes failed to undergo apo-
ptosis after treatment with various apoptotic stimuli,an excess of cells in CNS and decreased PCD of neuro-
epithelial cells (Kuida et al., 1996, 1998; Cecconi et al., including etoposide, g-irradiation, and dexamethasone.
Activated Apaf12/2 peripheral T cells were also more1998 [this issue of Cell], Hakem et al., 1998, and this
report). These mutants exhibit similar gross anatomical resistant to PCD induced by UV irradiation than control
cells. In contrast, the Fas-mediated apoptotic pathwayphenotypes, such as the protrusion of brain tissue at
the frontal bone area (Figure 3A). These findings are was intact in both mutant thymocytes and activated
peripheral T cells, demonstrating that Apaf1 is dispens-consistent with a scenario that newly generated neurons
within the ventricular zones, most of which should nor- able for Fas-induced PCD in these cells. In Fas-induced
PCD pathways, Casp8 is activated by the formation ofmally die while migrating toward superficial location, fail
to undergo PCD but proliferate, resulting in the abnor- a death-inducing signaling complex followed by Casp3
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activation (Muzio et al., 1996; Medema et al., 1997). This apoptotic mitochondrial events, including the release of
cytochrome c (Kluck et al., 1997; Yang et al., 1997) andFas-induced activation of Casp8 is devoid of proapo-
ptotic mitochondrial activity and is not inhibited by Bcl2 the permeability transition (Zamzami et al., 1995; Shi-
mizu et al., 1996). In this model, Apaf1 may work as(Scaffidi et al., 1998). Although recent studies demon-
strated that the cleavage of Bid by Casp8 induces the an activator molecule. In vitro, cytochrome c has been
shown to bind to APAF1, causing the activation ofrelease of cytochrome c and mitochondrial damage in
Fas-mediated cell killing (Li et al., 1998; Luo et al., 1998), CASP9, which in turn activates the key apoptotic en-
zyme CASP3 (Li et al., 1997a; Zou et al., 1997). It hasour data are therefore consistent with the notion that
the Fas-mediatedPCD pathway can bypass Bcl2/Apaf1/ been reported that cytochrome c release from mito-
chondria precedes DCm disruption (Kluck et al., 1997;mitochondrial events by directly activating Casp8 at the
level of the death receptors. However, in certain types Yang et al., 1997; Bossy-Wetzel et al., 1998), which is
linked to the opening of the PT pores (Kroemer et al.,of cells, Fas-induced activation of Casp8 occurs down-
stream of mitochondrial events (Scaffidi et al., 1998). 1997). Moreover, caspases have been shown to directly
induce the disruption of DCm (Susin et al., 1997; ScaffidiMoreover, Bcl2 family members have been reported to
have inhibitory effects on Fas-induced PCD in some et al., 1998). These reports are consistent with the idea
that Apaf1 functions in response to the release of cyto-types of cells (Takayama et al., 1995; Armstrong et al.,
1996; Boise and Thompson, 1997; Scaffidi et al., 1998). chrome c by activating caspases and that these cas-
pases can then trigger later mitochondrial damage.Therefore, it is also possible that theFas-induced activa-
tion of Casp8 observed in Apaf12/2 thymocytes is medi- Our finding that DCm was maintained in Apaf12/2 thy-
mocytes is in line with this model and suggests thatated by another Apaf1-like molecule(s), and that the
activation of Casp8 is regulated through its association Apaf1 functions upstream of DCm and the opening of
the PT pores. Moreover, the release of cytochrome cwith an Apaf1-like molecule and BclXL or related mole-
cules (Chinnaiyan et al., 1997). from mitochondria was not impaired in Apaf12/2 cells,
indicating that Apaf1 acts downstream of cytochrome
c release. Thus, a possible sequence of events may
Role of Apaf1 in a Common PCD Pathway entail the release of cytochrome c, which promotes ac-
Apoptosis can be divided into at least three functionally tion by Apaf1 to regulate the activation of certain cas-
distinct stages: the initiation, effector, and degradation pases, followed by the caspase-induced proteolytic
phases (Kroemer et al., 1995). Distinct apoptotic stimuli events including the disruption of DCm and PT, as has
initiate distinct biochemical events during the heteroge- been suggested by Bossy-Wetzel et al. (1998).
neous initiation phase. However, during the subsequent
effector phase, these distinct initiating events are trans-
lated into more common events such as the activation Downstream Effectors of Apaf1
What molecules lie immediately downstream of Apaf1?of specific caspases. In the degradation phase, phe-
nomena universal to apoptosis induced by all stimuli APAF1 has been shown in vitro to interact with CASP4,
CASP8, and CASP9 (Li et al., 1997a; Hu et al., 1998; Panare observed, including protein degradation, membrane
alterations, and DNA cleavage. et al., 1998), molecules that contain long prodomains
and that are thought to function early in the caspaseThe proapoptotic role of Apaf1 previously demon-
strated in vitro (Li et al., 1997a; Zou et al., 1997) has cascade (Golstein, 1997). Studies in vitro have demon-
strated that APAF1 has a stronger affinity for CASP9been confirmed in vivo and ex vivo in this study. Apaf1-
deficient ES cells, EF cells, and thymocytes were re- than for other caspases, suggesting that in certain situa-
tions, the predominant regulatory target of APAF1 ismarkably resistant to a wide range of apoptotic stimuli.
The apoptotic pathways found in ES and EF cells (and CASP9 (Pan et al., 1998). While Casp92/2 EF cells are
resistant to various apoptotic stimuli (Hakem et al., 1998),probably neuronal cells) are similar to the apoptotic
pathways in C. elegans in that they are all dependent they are invariably more resistant than are Apaf12/2 EF
cells (H. Y. and T. W. M., unpublished observations).on Apaf1 (CED-4). However, our results also show that
the dependence of apoptotic pathways on Apaf1 may These observations are consistent with a hypothesis
that Casp9 is the predominant regulatory target of Apaf1vary in different types of cells or in different types of
tissues or organs, as demonstrated by the differential in EF cells.
Apaf12/2 thymocytes, likeCasp92/2 thymocytes,showedsusceptibility to PCD of ES and EF cells. The broad
spectrum of protection evident in Apaf1-deficient cells remarkable resistance to apoptotic stimulations (Hakem
et al., 1998; Kuida et al., 1998; and Figure 5). Thymocytessuggests that Apaf1 plays a critical role in a common
pathway, translating and converging different initiating of both mutant mice showed reduced activation of
Casp3 in response to these stimulations (Figure 6A).events induced by different apoptotic stimuli into shared
effector events. This scenario is reminiscent of the anti- Thus, in thymocytes, Casp9 is likely downstream of
Apaf1. However, we have shown in this study that bothapoptotic function of Bcl2, in that Bcl2 blocks apoptosis
under a variety of conditions (Hockenbery et al., 1990; Casp8 and Casp2 can be regulated downstream of
Apaf1. This result indicates that Apaf1can regulate otherSentman et al., 1991; Korsmeyer, 1992; Reed, 1994).
One model that has been proposed to account for the caspases in addition to Casp9. Moreover, CASP8 has
been shown to interact with CED-4 (Chinnaiyan et al.,action of Bcl2 and its antiapoptotic homologs is that
these molecules act by stabilizing the mitochondrial 1997) or with APAF1 (Hu et al., 1998) through its long
prodomain (Hofmann et al., 1997). It is therefore likelymembrane and/or preventing the release of cytochrome
c from mitochondria. The overexpression of Bcl2 inhibits that Casp8 lies downstream of Apaf1 and is regulated
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chimeras was performed as described previously (Yoshida et al.,via an association with Apaf1. Since recombinant CASP8
1998).was able to activate all known caspases (including
CASP1±CASP7, CASP9, and CASP10) in vitro (Sriniva-
Histological Analysis
sula et al., 1996), it is possible that Apaf1-mediated Uteri from plugged females were isolated in ice-cold phosphate-
regulation of Casp8 plays a role in PCD in response to buffered saline at E11.5 to E16.5, fixed overnight in 4% paraformal-
multiple stimuli. dehyde at 48C, dehydrated, and embedded in paraffin. Sections 7
mm thick were cut and stained with thionine.Although the association of Casp2 with Apaf1 has not
been proven, Casp2 may also be a downstream effector
In Situ Hybridizationof Apaf1. Casp2 is classified as an upstream enzyme
For whole-mount in situ hybridization, E9.5 embryos were fixed and
in caspase cascade, because it has a long prodomain processed according to standard protocols. The Apaf1 probe used
(Kumar et al., 1994). In our experiments, the proteolytic was a 400 bp murine cDNA probe synthesized by RT-PCR cloned
activation of Casp2 was reduced in Apaf12/2 thymo- into the pCRII vector (TA cloning kit, Invitrogen). Probes were syn-
thesized from linearized vector with SP6 or T7 RNA polymerase,cytes, suggesting that Casp2 is also downstream of
labeled with digoxigenin-UTP, and processed as previously de-Apaf1. However, it remains possible that the activation
scribed (Hui and Joyner, 1993).of Casp2 and Casp8 is not directly controlled by Apaf1
but is instead regulated by other caspases such as BrdU Labeling of Embryos
Casp3 or Casp9 (Li et al., 1997b; Hakem et al., 1998). BrdU labeling of cells in the S phase of the cell cycle was performed
In summary, our results demonstrate that Apaf1 is according to the protocol described previously (Hakem et al., 1998).
Briefly, BrdU (100 mg/g of body weight) was injected intraperitoneallycrucial for PCD in the developing brain during the em-
into pregnant females. The females were sacrificed 1 hr after injec-bryogenesis. We also show that Apaf1 plays a central
tion, and the embryos were removed, fixed, dehydrated, and sec-role in the common effector phase of mitochondrial PCD
tioned as for histological analysis. The sections were incubated with
pathways in various cell types, possibly by regulating an anti-BrdU monoclonal antibody (Becton Dickinson) at a 1:10
the activation of Casp2, Casp3, and Casp8. However, dilution. The labeling index (BrdU positive nuclei per total nuclei)
Fas-induced PCD in thymocytes and activated T cells was calculated from three serial sections of the mutants and their
littermates. At least two mutants were used for each stage of gesta-is independent of Apaf1. Our results also imply the exis-
tion with similar tendency.tence of otherCED-4/Apaf1-like molecules, the isolation
and analysis of which may shed more light on mitochon-
Detection of Apoptosis
drial pathways of PCD. Detection of apoptosis in the brain was performed by the TUNEL
method using the In Situ Cell Death Detection kit (Boehringer Mann-
heim) according to the manufacturer's directions.
Experimental Procedures
Induction of Apoptosis in ES Cells and EF CellsCells
To assay PCD of ES cells or EF cells, 1 3 105 cells were plated inE14K embryonic stem cells from 129/Ola mice were maintained on
each well of a 24-well dish one day prior to treatment. The cellsa layer of mitomycin C±treated embryonic fibroblasts in Dulbecco's
were left untreated or treated with anisomycin (50 mM); etoposidemodified Eagle's culture medium (DMEM), supplemented with leu-
(10 or 100 mM), cisplatinum (10 or 50 mM), or staurosporine (2 or 10kemia inhibitory factor, 15% fetal calf serum (FCS), L-glutamine, and
mM) (all from Sigma); or UV irradiation (120 mJ/cm2) (Stratalinker
b-mercaptoethanol. Apaf12/2 embryonic fibroblasts were obtained
2400, Stratagene). After treatment, cells were trypsinized and col-from E14.5 embryos and cultured in DMEM supplemented with 5%
lected with the supernatants, and cell viability was determined byFCS, L-glutamine, and b-mercaptoethanol.
propidium iodide (PI) and annexin V staining using the Apoptosis
Detection Kit (R & D systems) according to the manufacturer's direc-
tions. Triplicate samples of each treatment in three independentGeneration of Apaf12/2 Mutant Mice
experiments were assayed.Murine Apaf1 gene fragments were cloned from a 129/J genomic
DNA library using a PCR-amplified human APAF1 cDNA probe. Prim-
Immunohistochemistry for the Localizationers used for amplification of human APAF1 cDNA commenced at
of Cytochrome cpositions 909 and 1321 (59-GGC CAG TTG TTT TTG TCA A-39 and 59-
Apaf11/2 or Apaf12/2 EF cells were grown on 1 mm glass coverslipsCTG GTT GTA AGA AGA ATC-39). Five overlapping phage genomic
for 24 hr and stimulated with etoposide (100 mM), staurosporine (2clones containing exons encoding Walker A and Walker B nucleo-
mM), or UV irradiation (240 mJ/cm2). Four hours after stimulation,tide-binding P-loop domains (Walker et al., 1982) were isolated. A
cells were examined for the intracellular localization of cytochrometargeting vector was designed to replace a 4.0 kb genomic fragment
c as described elsewhere (Bossy-Wetzel et al., 1998) using anti-containing an exon encoding a portion of the P loop with a neomycin
cytochrome c antibodies (7H8.2C12, PharMingen) and PI staining.resistance cassette. The neomycin resistance gene (neo) was in-
serted in the targeting vector in the sense orientation to Apaf1 tran-
Induction of Thymocyte Apoptosisscription, such that neo was flanked on the 39 side by 0.8 kb of
Freshly isolated thymocytes from Apaf12/2 mice and their controlgenomic DNA and on the 59 side by 4 kb of genomic DNA. The
littermates (10 days old), or Apaf12/2/Rag12/2 and Apaf11/2/Rag12/2targeting vector was linearized with XhoI and electroporated into
somatic chimeric mice (6 to 8 weeks old), were plated in wells of aE14K ES cells. After G418 selection (200 mg/ml, GIBCO-BRL), homol-
48-well dish at 1 3 106 cells/ml in RPMI medium supplemented withogous recombinants were identified by PCR using a specific primer
10% FCS. Cells were stimulated with anti-Fas antibody (Jo-2 clone,pair (59-GGG CCA GCT CAT TCC TC-39 and 59-CAC TCT AGT GTC
PharMingen, 1 mg/ml) plus cycloheximide (0±1.0 mg/ml); dexametha-CAG GCT ATC-39) and confirmed by Southern blotting according to
sone (1±1000 nM); etoposide (2±50 mM); staurosporine (0.5±10 mM);standard protocols. Clones heterozygous for the targeted mutation
and g-irradiation (100±1000 rad), and were stained with PI vs.were injected into 3.5-day C57BL/6 blastocysts, which were subse-
annexin V (20 hr after stimulation) or DiOC6(3) (6 hr after stimulation)quently transferred into pseudopregnant foster mothers. Chimeric
(Molecular Probes) according to the manufacturer's directions.mice werecrossed into strains C57BL/6 or CD1 to produce heterozy-
gous mutant mice. Germline transmission of the mutation was veri-
fied by PCR and Southern blot analysis of tail DNA. The null pheno- Assay for Activation-Induced Cell Death
Splenocytes from Apaf12/2/Rag12/2 and Apaf11/2/Rag12/2 chimerictype of Apaf12/2 mice was confirmed by Northern blot analysis.
Generation of Apaf12/2 ES cell lines and Apaf12/2/Rag12/2 somatic mice were stimulated with anti-CD3e antibody (2 mg/ml) for 24 hr.
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Cells were then cultured in 10% Con A-conditioned medium. After a novel human apoptotic protein with homology to Caenorhabditis
elegans cell death protein Ced-3 and mammalian interleukin-1 beta-4 days of culture, cells were treated with anti-Fas antibody (1 mg/
ml) for 6 or 24 hr, and cell viability was determined by flow cytometry converting enzyme. J. Biol. Chem. 269, 30761±30764.
using 7-AAD. Golstein, P. (1997). Controlling cell death. Science 275, 1081±1082.
Hakem, R., Hakem, A., Duncan, G.S., Henderson, J.T., Woo, M.,
Western Blot Analysis Soengas, M. S., Elia, A., de la Pompa, J.L., KaÈgi, D., Khoo, W., Potter,
Thymocytes from newborn mice or Rag12/2 chimeric mice were J., Yoshida, R., Kaufman, S.A., Lowe, S.W., Penninger, J.M., and
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